Cargando…

IPVS Policy statement on safety of HPV vaccines

Detalles Bibliográficos
Autor principal:	.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886868/ https://www.ncbi.nlm.nih.gov/pubmed/29074192 http://dx.doi.org/10.1016/j.pvr.2015.11.001

Ejemplares similares

IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples
por: Lawton, Beverley, et al.
Publicado: (2019)

IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity”
por: Garland, Suzanne M., et al.
Publicado: (2020)

IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some
por: Brotherton, Julia, et al.
Publicado: (2019)

IPVS statement moving towards elimination of cervical cancer as a public health problem
por: Garland, SM, et al.
Publicado: (2018)

Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
por: Mangarule, S., et al.
Publicado: (2022)

The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants
por: Kang, Jin Han, et al.
Publicado: (2016)

First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age
por: Lindgren, Line M., et al.
Publicado: (2017)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
por: Zhang, Yuntao, et al.
Publicado: (2022)

IPv6 fundamentals: a straightforward approach to understanding IPv6
por: Graziani, Rick
Publicado: (2017)

WLCG and IPv6 - the HEPiX IPv6 working group
por: Campana, S, et al.
Publicado: (2014)

IPv6 fundamentals: a straightforward approach to understanding IPv6
por: Graziani, Rick
Publicado: (2013)

Cisco self-study: implementing IPv6 networks (IPV6)
por: Desmeules, Régis
Publicado: (2003)

IPv6 Security
por: Babik, M, et al.
Publicado: (2017)

IPv6 essentials
por: Hagen, Silvia
Publicado: (2014)

IPv6 security
por: Hogg, Scott, et al.
Publicado: (2009)

Understanding IPv6
por: Davies, Joseph
Publicado: (2012)

Understanding IPv6
por: Davies, Joseph
Publicado: (2008)

IPv6 Essentials
por: Hagen, Silvia
Publicado: (2006)

Planning for IPv6
por: Hagen, Silvia
Publicado: (2011)

IPV6 essentials
por: Hagen, Silvia
Publicado: (2002)

CAEP Position Statement Executive Summary: Where is the love? Intimate partner violence (IPV) in the Emergency Department (ED)
por: Khatib, Nour, et al.
Publicado: (2022)

From IPv4 to eternity - the HEPiX IPv6 working group
por: Martelli, Edoardo
Publicado: (2012)

From Endorsement of Ambivalent Sexism to Psychological IPV Victimization: The Role of Attitudes Supportive of IPV, Legitimating Myths of IPV, and Acceptance of Psychological Aggression
por: Cinquegrana, Vincenza, et al.
Publicado: (2022)

IPv6 : theory, protocol, and practice /
por: Loshin, Peter
Publicado: (2004)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
por: Lalwani, Sanjay K., et al.
Publicado: (2016)

Migrating to IPv6 : a practical guide to implementing IPv6 in mobile and fixed networks /
por: Blanchet, Marc, 1964-
Publicado: (2006)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age
por: Bravo, Lulu C., et al.
Publicado: (2020)

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
por: Mangarule, S, et al.
Publicado: (2022)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

IPv6 address planning
por: Coffeen, Tom
Publicado: (2015)

IPv6 Network Administration
por: Murphy, Niall Richard, et al.
Publicado: (2009)

IPv6 network programming
por: Hagino, Jun-ichiro itojun
Publicado: (2005)

Deploying IPv6 networks
por: Popoviciu, Ciprian, et al.
Publicado: (2006)

IPv6 for enterprise networks
por: McFarland, Shannon
Publicado: (2011)

DNS and BIND on IPv6
por: Liu, Cricket
Publicado: (2011)

Migrating Applications to IPv6
por: York, Dan
Publicado: (2011)

IPv6 deployment and management
por: Dooley, Michael, et al.
Publicado: (2013)

Security in an IPv6 Environment
por: Minoli, Daniel, et al.
Publicado: (2016)

Linear and non-linear video and TV applications: using IPv6 and IPv6 multicast
por: Minoli, Daniel
Publicado: (2012)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15–18 months
por: Sáez-Llorens, Xavier, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2cmb91pm16cv4b72t7fqh1m4e